Salla, M.; Karaki, N.; El Kaderi, B.; Ayoub, A.J.; Younes, S.; Abou Chahla, M.N.; Baksh, S.; El Khatib, S.
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It? Pharmaceutics 2024, 16, 569.
https://doi.org/10.3390/pharmaceutics16040569
AMA Style
Salla M, Karaki N, El Kaderi B, Ayoub AJ, Younes S, Abou Chahla MN, Baksh S, El Khatib S.
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It? Pharmaceutics. 2024; 16(4):569.
https://doi.org/10.3390/pharmaceutics16040569
Chicago/Turabian Style
Salla, Mohamed, Nadine Karaki, Belal El Kaderi, Abeer J. Ayoub, Samar Younes, Maya N. Abou Chahla, Shairaz Baksh, and Sami El Khatib.
2024. "Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?" Pharmaceutics 16, no. 4: 569.
https://doi.org/10.3390/pharmaceutics16040569
APA Style
Salla, M., Karaki, N., El Kaderi, B., Ayoub, A. J., Younes, S., Abou Chahla, M. N., Baksh, S., & El Khatib, S.
(2024). Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It? Pharmaceutics, 16(4), 569.
https://doi.org/10.3390/pharmaceutics16040569
